Liver cancer, primarily hepatocellular carcinoma (HCC), is the third most common contributor to cancer-related deaths worldwide. Early-stage HCC has a better prognosis than advanced-stage HCC and can be treated with minimally invasive surgery, including robotic-assisted and laparoscopic options. However, few studies have examined the presumably unique and discrepant short-term and long-term outcomes of robotic-assisted and laparoscopic surgeries. Read more.
Breast-conserving surgery (BCS) plus radiotherapy is the standard-of-care for women diagnosed with early-stage breast cancer. For women over age 70, however, radiotherapy after BCS is controversial, and U.S. National Comprehensive Cancer Network clinical practice guidelines recommend that it may be omitted.
The TAILORx study published last year offered good news for women with early-stage ER-positive breast cancer who scored at intermediate risk for recurrence according to a genetic assay test. The study indicated that chemotherapy after surgery provided little advantage in overall survival for these women, so they could forgo the treatment.
Six clinics across four U.S. states provided data for a newly validated clinical risk stratification model for lung cancer. The TREAT model (Thoracic Surgery, Research, Epidemiology, Diagnosis And Treatment) helps identify patients with suspicious lesions who are most likely to benefit from surgical biopsy. The aim is to mitigate unnecessary surgery for benign nodules and reduce delays for patients with early cancers.
In a review of 526,690 patients who underwent radical prostatectomy for localized prostate cancer, researchers from Vanderbilt University Medical Center found Black patients had significantly higher mortality rates compared to other racial and ethnic groups. Asian Americans and Pacific Islanders (AAPIs) had notably lower mortality rates than non-Hispanic whites. Hispanics had slightly lower rates than non-Hispanic whites – despite lower socioeconomic status and significant underinsurance.
Conventional colorectal adenomas are the precursor lesions for most colorectal cancers. In addition to these adenomas, other colorectal polyps are detected during colonoscopy. Sessile serrated polyps (SSPs) represent an alternative pathway to carcinogenesis that may account for 20-30% of colorectal cancer. Because a diagnostic consensus for SSPs was not reached until 2010, few epidemiologic studies have evaluated risk factors for SSPs.